Century Therapeutics (IPSC) Prepaid Assets (2020 - 2026)
Century Therapeutics (IPSC) reported Prepaid Assets of $4.2 million for Q1 2026, down 6.08% year-over-year from $4.5 million in Q1 2025, and up 15.9% quarter-over-quarter from $3.7 million in Q4 2025.
Century Therapeutics (IPSC) Prepaid Assets (2020 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has 7 years of Prepaid Assets data on file, last reported at $4.2 million in Q1 2026.
- Prepaid Assets for Q1 2026 came in at $4.2 million, down 6.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.2 million (down 6.08% YoY), and the FY2025 annual result was $3.7 million, up 1274.06% from the prior year.
- Prepaid Assets climbed to $4.2 million in Q1 2026 per IPSC's latest filing, from $3.7 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $7.9 million in Q3 2024 and troughed at $266000.0 in Q4 2024.
- A 5-year average of $3.8 million and a median of $4.2 million in 2023 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2022 and 2023: Prepaid Assets jumped 1501.2% in 2022, then slumped 80.99% in 2023.
- A 5-year view of Prepaid Assets shows it stood at $4.0 million in 2022, then tumbled by 80.99% to $761000.0 in 2023, then plunged by 65.05% to $266000.0 in 2024, then jumped by 1274.06% to $3.7 million in 2025, then increased by 15.9% to $4.2 million in 2026.
- Business Quant data shows IPSC's Prepaid Assets at $4.2 million in Q1 2026, $3.7 million in Q4 2025, and $5.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Century Therapeutics | 444.99 Mn | 444.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.24 Mn |
| Dec 31, 2025 | 3.66 Mn |
| Sep 30, 2025 | 4.96 Mn |
| Jun 30, 2025 | 4.33 Mn |
| Mar 31, 2025 | 4.51 Mn |
| Dec 31, 2024 | 266,000.00 |
| Sep 30, 2024 | 7.90 Mn |
| Jun 30, 2024 | 7.08 Mn |
| Mar 31, 2024 | 7.80 Mn |
| Dec 31, 2023 | 761,000.00 |
| Sep 30, 2023 | 4.20 Mn |
| Jun 30, 2023 | 4.88 Mn |
| Mar 31, 2023 | 884,000.00 |
| Dec 31, 2022 | 4.00 Mn |
| Sep 30, 2022 | 1.82 Mn |
| Jun 30, 2022 | 2.37 Mn |
| Mar 31, 2022 | 817,000.00 |
| Dec 31, 2021 | 250,000.00 |
| Sep 30, 2021 | 4.74 Mn |
| Jun 30, 2021 | 4.63 Mn |